Amgen Inc. v. Sanofi

  1. August 21, 2020

    Pharma Giants Tee Up Biologics Innovation Fight At Fed. Circ.

    In the middle of a pandemic where antibodies are at the center of prevention and treatment research, the Federal Circuit is weighing a case that could deeply impact how drugmakers can patent biologics, an issue that is not only critical to coronavirus research but to pharma at large.

  2. July 09, 2020

    Patent Cases To Watch In The Second Half Of 2020

    A wave of U.S. Supreme Court petition denials has made 2020 a bit of a letdown for patent attorneys, but there are several high-profile cases on the horizon that could decide the fate of Patent Trial and Appeal Board judges and biosimilars law, and offer more clarity on licensing standard essential patents.